| 1.46 0.1 (7.35%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.83 | 1-year : | 2.04 |
| Resists | First : | 1.57 | Second : | 1.75 |
| Pivot price | 1.42 |
|||
| Supports | First : | 1.28 | Second : | 1.07 |
| MAs | MA(5) : | 1.44  |
MA(20) : | 1.41 |
| MA(100) : | 1.34 |
MA(250) : | 1.96 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 22 |
D(3) : | 25.2 |
| RSI | RSI(14): 52.2 |
|||
| 52-week | High : | 5.8 | Low : | 0.76 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CGC ] has closed below upper band by 41.1%. Bollinger Bands are 32.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.54 - 1.55 | 1.55 - 1.56 |
| Low: | 1.32 - 1.33 | 1.33 - 1.34 |
| Close: | 1.45 - 1.46 | 1.46 - 1.47 |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Wed, 15 Oct 2025
Is Canopy Growth Set for a Rebound? - timothysykes.com
Wed, 15 Oct 2025
Is Most-Watched Stock Canopy Growth Corporation (CGC) Worth Betting on Now? - Yahoo Finance
Tue, 14 Oct 2025
Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders - Yahoo Finance
Mon, 13 Oct 2025
How Will Canopy Growth’s Medical Craft Cannabis Pivot Affect Long-Term Strategy for TSX:WEED Investors? - Yahoo Finance
Mon, 13 Oct 2025
Canopy Growth Corporation (CGC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Fri, 10 Oct 2025
Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 312 (M) |
| Shares Float | 240 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 5.5 (%) |
| Shares Short | 22,670 (K) |
| Shares Short P.Month | 21,100 (K) |
| EPS | -3.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.38 |
| Profit Margin | -186.5 % |
| Operating Margin | -24.8 % |
| Return on Assets (ttm) | -3.5 % |
| Return on Equity (ttm) | -101.1 % |
| Qtrly Rev. Growth | 8.8 % |
| Gross Profit (p.s.) | 0.24 |
| Sales Per Share | 0.88 |
| EBITDA (p.s.) | -0.07 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -124 (M) |
| Levered Free Cash Flow | -93 (M) |
| PE Ratio | -0.49 |
| PEG Ratio | 0 |
| Price to Book value | 0.61 |
| Price to Sales | 1.65 |
| Price to Cash Flow | -3.67 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|